The study included 211 head and neck cancers from the oropharynx.

Dr. Luo continued, ‘The outcome of this study may be the first concrete proof that people have made significant improvement toward this goal.’.. ADC announces RNAscope technology clinical study results for HPV-associated neck and head cancers Advanced Cell Diagnostics, Inc. These outcomes will be shown today at the 100th annual meeting of USA & Canadian Academy of Pathology . The study included 211 head and neck cancers from the oropharynx .23, p < 0.001 for overall survival and disease-specific survival), in comparison to HPV-harmful tumors.Our medical data indicate APD421 is an efficient dopamine antagonist antiemetic, which includes the potential to become mainstay of therapy, contributing greatly to the well-being of sufferers following surgery. Dr Gabriel Fox, Acacia Pharma's CMO, added: Dopamine antagonists were a favorite and very efficacious choice for anaesthetists wanting to prevent PONV, before emergence of safety concerns such as heart rhythm disturbances and movement disorders. Acacia Pharma set out to develop an effective and safe dopamine antagonist to add back into the armamentarium of antiemetics for the management of PONV.